Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivo

Cancer Gene Therapy

Volumn 17, Issue 11, 2010, Pages 771-779

  Li, J ^a   Shi, L ^a   Zhang, X ^a   Kang, X ^a   Wen, Y ^a   Qian, H ^a   Zhou, Y ^a   Xu, W ^a   Zhang, Y ^a   Wu, M ^a   Yin, Z ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; Bax; hepatic cancer; IL 24; IL 24 Bax; recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; HYBRID PROTEIN; INTERLEUKIN 24; INTERLEUKIN 24 BAX FUSION PROTEIN; PROTEIN BAX; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; GENE THERAPY; GENETIC VECTORS; HUMANS; INTERLEUKINS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 77958081674     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2010.34     Document Type: Article

References (33)

1. Pastan IHassan RFitzGerald DJ Kreitman RJ. Immu-notoxin treatment ofcancer. Annu Rev Med. 2007. 58. 221-237.
2. Jarboe JS, Johnson KR, Choi Y, Lonser RR, Park JK. Expression ofinterleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 2007; 67: 7983-7986.
3. Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C. IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood 2007; 110: 3192-3201.
4. Frankel A, Liu JS, Rizzieri D, Hogge D. Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia. Leuk Lymphoma 2008; 49: 543-553.
5. Aqeilan R, Yarkoni S, Lorberboum-Galski H. Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy. FEBS Lett 1999; 457: 271-276.
6. Ben-Yehudah A, Aqeilan R, Belostotsky R, Azar Y, Lorberboum-Galski H. Utilizing chimeric proteins for exploring the cellular fate of endogenous proteins. Biochem Biophys Res Commun 2002; 290: 332-338.
7. Dansen TB, Whitfield J, Rostker F, Brown-Swigart L, Evan GI. Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo. J Biol Chem 2006; 281: 10890-10895.
8. Toyota H, Kondo S, Kyo S, Mizuguchi J. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) pro-moter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Anticancer Res 2006; 26: 99-105.
9. Krop EJ, Matsui EC, Sharrow SD, Stone MJ, Gerber P, van der Zee JS et al. Recombinant major urinary proteins of the mouse in specific IgE and IgG testing. Int Arch Allergy Immunol 2007; 144: 296-304.
10. Tobiume K. Involvement of Bcl-2 family proteins in p53-induced apoptosis. J Nippon Med Sch 2005; 72: 192-193.
11. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
12. Schweinfest CW, Nelson PS, Graber MW, Demopoulos RI, Papas TS. Subtraction hybridization cDNA libraries. Methods Mol Biol 1995; 37: 13-30.
13. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB. The melanoma differentiation associated gene mda-7 sup-presses cancer cell growth. Proc Natl Acad Sci USA 1996; 93: 9160-9165.
14. Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003; 22: 1164-1180.
15. Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S et al. Loss of MDA-7 expression with progression of melanoma. J Clin Oncol 2002; 20: 1069-1074.
16. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K et al. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA 2002; 99: 10054-10059.
17. Sauane M, Su ZZ, Gupta P, Lebedeva IV, Dent P, Sarkar D et al. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci USA 2008; 105: 9763-9768.
18. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, Su ZZ et al. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J Cell Physiol 2003; 196: 334-345.
19. Chada S, Mhashilkar AM, Ramesh R, Mumm JB, Sutton RB, Bocangel D et al. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Mol Ther 2004; 10: 1085-1095.
20. Friedman SL, Shaulian E, Littlewood T, Resnitzky D, Oren M. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene 1997; 15: 63-70.
21. Zhao J, Wang H, Wei L, Habib NA, Lu X, Wu M et al. The cytotoxic effect ofE1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines. Cancer Gene Ther 2001; 8: 333-341.
22. Chen WY, Cheng YT, Lei HY, Chang CP, Wang CW, Chang MS. IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun 2005; 6: 493-499.
23. Zhang X, Kang X, Shi L, Li J, Xu W, Qian H et al. mda-7/IL-24 induces apoptosis in human HepG2 hepatoma cells by endoplasmic reticulum stress. Oncol Rep 2008; 20: 437-442.
24. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-1763.
25. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA et al. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 2003; 22: 8758-8773.
26. Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P et al. MDA-7 regulates cell growth and radio-sensitivity in vitro of primary (non-established) human glioma cells. Cancer Biol Ther 2004; 3: 739-751.
27. Sieger KA, Mhashilkar AM, Stewart A, Sutton RB, Strube RW, Chen SY et al. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol Ther 2004; 9: 355-367.
28. Sauane M, Gupta P, Lebedeva IV, Su ZZ, Sarkar D, Randolph A et al. N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and 'bystander' antitumor activity. Cancer Res 2006; 66: 11869-11877.
29. Park MA, Yacoub A, Sarkar D, Emdad L, Rahmani M, Spiegel S et al. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy 2008; 4: 513-515.
30. Qian W, Liu J, Tong Y, Yan S, Yang C, Yang M et al. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia 2008; 22: 361-369.
31. Yacoub A, Park MA, Gupta P, Rahmani M, Zhang G, Hamed H et al. Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Mol Cancer Ther 2008; 7: 297-313. (Pubitemid 351302524)
32. Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW et al. MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int Immuno-pharmacol 2004; 4: 649-667.
33. Kreis S, Philippidou D, Margue C, Behrmann I. IL-24: a classic cytokine and/or a potential cure for cancer? J Cell Mol Med 2008; 12: 2505-2510.